Human IgG antibody Laboratories manufactures the gentarget inc cat lvp023 san diego ca reagents distributed by Genprice. The Gentarget Inc Cat Lvp023 San Diego Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact GenTarget. Other Gentarget products are available in stock. Specificity: Gentarget Category: Inc Group: Cat Lvp023
CA/ Rat CA ELISA Kit |
|||
| ELA-E0875r | Lifescience Market | 96 Tests | EUR 886 |
CAT/ Rat CAT ELISA Kit |
|||
| ELA-E0242r | Lifescience Market | 96 Tests | EUR 886 |
San Miguel sea lion viral disease PCR kit |
|||
| PCR-V276-48R | Bioingentech | 50T | EUR 823 |
San Miguel sea lion viral disease PCR kit |
|||
| PCR-V276-96R | Bioingentech | 100T | EUR 1113 |
Chicken PM20D1 (Probable carboxypeptidase PM20D1) ELISA Kit (San |
|||
| ELI-22098c | Lifescience Market | 96 Tests | EUR 928 |
AN3 CA |
|||
| C0026002 | Addexbio | One Frozen vial | EUR 543 |
CA-074 |
|||
| HY-103350 | MedChemExpress | 10mg | EUR 587 |
CA-5f |
|||
| HY-112698 | MedChemExpress | 5mg | EUR 176 |
CA 074 |
|||
| A1926-1 | ApexBio | 1 mg | EUR 148 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-10 | ApexBio | 10 mg | EUR 485 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-25 | ApexBio | 25 mg | EUR 746 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5 | ApexBio | 5 mg | EUR 311 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 432 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA-1001 |
|||
| B2669-25 | Biovision | 25mg | EUR 591 |
CA-1001 |
|||
| B2669-5 | Biovision | 5mg | EUR 186 |
CA-074 |
|||
| B2971-1 | Biovision | 1 mg | EUR 196 |